Completed
Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
NCT01920555
- Conditions
- Behavior, Behavioral Symptoms, Depression, +6 more
- Locations
-
- Stanford University Palo Alto, California, United States
- Yale University New Haven, Connecticut, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Mount Sinai School of Medicine New York, United States